MissionIR

Friday Aug 16, 2024 - 3:03 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD

InMed Pharmaceuticals (NASDAQ: INM), a clinical stage company developing a pipeline of pharmaceutical drug candidates to treat several diseases with a high unmet medical need, is at the forefront of developing innovative treatment for age-related macular degeneration (“AMD”), with its flagship product INM-089 showing great promise. “AMD is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part…

Friday Aug 16, 2024 - 2:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Opportunity from First-Ever Work with Tirzepatide Molecule

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently hired a Contract Research Organization (“CRO”) for its third human pilot study. “This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (‘GLP-1’) studies for the 2024 calendar year… This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (‘GIP’), specifically…

Friday Aug 16, 2024 - 2:09 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Addressing ‘Significant Problem’ with Resilient Energy Solutions

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is driving scalability in the microgrid energy distribution market. This follows a new partnership between its subsidiary Distributed Energy Capital (“DEC”) and clean energy development innovator Compass Energy that will establish the United States’ first microgrid utility. “The landmark initiative by Distributed Energy Capital and Compass Energy Platform…

Wednesday Aug 14, 2024 - 2:00 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) CEO Showcases Strategic Approach to Industry

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving its public perception. “The central theme of McEwen’s speech was…

Friday Jul 12, 2024 - 12:04 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Expanding Solutions to Significant Untapped Market

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically working with partners to help clients facilitate green energy transition and improvements. “Correlate Energy is expanding its renewable energy adoption services into a significant untapped market, thanks to a new corporate partnership, a new federal funding program benefitting low-income communities, and a non-profit insurance company designed…

Thursday Jul 11, 2024 - 2:30 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Standout Opportunity for Investors

McEwen Mining’s (NYSE: MUX) (TSX: MUX) share price has shown a remarkable gain of 62.1% over the last 12 weeks, indicating strong momentum and robust performance in the market. “This trend of sustained positive momentum over time is a key indicator of the stock’s potential for continued growth, making it an attractive option for those looking to capitalize on price strength… McEwan Mining’s financial health…

Thursday Jul 11, 2024 - 2:00 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment

InMed (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. The company recently released several critical updates regarding its INM-089 therapy treating dry Age-related Macular Degeneration (“AMD”) and its INM-901 small molecule drug candidate targeting Alzheimer’s disease (“AD”). “Recent preclinical data for INM-089 demonstrated significant functional and pathological improvements in an…

Wednesday Jul 10, 2024 - 12:30 pm

InvestorNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Sets New Standard for Accuracy, Reliability in Narcotics Detection

Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. “With recent approval as a U.S. General Services Administration (‘GSA’) authorized vendor, 1st Detect is poised to expand its impact across government agencies. TRACER 1000 is a cutting-edge detector utilizing ruggedized mass spectrometry technology for superior detection at critical security points. 1st Detect’s commitment to excellence is underscored by its…

Monday Jul 01, 2024 - 12:37 pm

InvestorNewsBreaks – PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones

PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorders, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for using suramin to treat Human African Trypanosomiasis (“HAT”), a well-established treatment in East Africa for nearly a century. A recent article discussed PaxMedica gearing up for a significant Type C meeting it had with the FDA, which…

Friday Jun 28, 2024 - 2:30 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Helping Companies ‘Beat the Grid for Costs’

Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. “Correlate Energy is a unique source for helping make renewable energy accessible to companies seeking to transition from more carbon-intensive fuels as part of a worldwide effort to forestall the harms of pollution-driven changes to the environment. The company’s focus on solar energy infrastructure, for example, is…

Thursday Jun 27, 2024 - 3:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes… The company recently received independent third-party ethics review…

Monday Mar 25, 2024 - 10:45 am

InvestorNewsBreaks — The Register Interviews D-Wave Quantum Inc. (NYSE: QBTS), Highlights Quantum Computing’s Potential Impact on AI

The Register, a British technology news website with millions of unique visitors per month, recently published an article about OpenAI’s recent interest in quantum. To gain insight, The Register interviewed Murray Thom, D-Wave's VP of Quantum Technology Evangelism, and Trevor Lanting, D-Wave's Chief Development Officer. Lanting explained, "As you're training [an AI] model, the number of parameters that go into the model really drives the…

Thursday Mar 21, 2024 - 12:15 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Continuing to Redefine Logistics Landscape with Innovative Solutions

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has been Riisa’s trusted logistics supplier for over two years, facilitating cross-border exportations and enabling Riisa to move its products with ease and efficiency. In Fr8App’s continued focus on redefining the logistics landscape, it…

Thursday Mar 21, 2024 - 11:58 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO to Present at the Upcoming 14th Annual LD Micro Invitational

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that it will be participating at the 14th Annual LD Micro Invitational at the Sofitel New York on Apr. 8-9, 2024. Lexaria CEO Chris Bunka will be presenting at the event, with his presentation scheduled to begin at 10:30 a.m. ET on Tuesday, Apr. 9. Bunka will discuss the company’s recent…

Thursday Mar 21, 2024 - 11:33 am

InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR), CEO Recognized at FiNext Conference with Excellence in Finance Awards

FingerMotion (NASDAQ: FNGR), a mobile services and data company, and CEO Martin J. Shen, received recognition at the recent FiNext Conference. At the conference, which was held in Dubai on Feb. 28–29, 2024, FingerMotion and Shen both received awards. Shen was awarded the Excellence in Finance — Leaders Award, and the company was awarded the Excellence in Finance — Companies Award. The Excellence in Finance…

Thursday Mar 21, 2024 - 9:54 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, has been granted an additional 180 days to comply with NASDAQ’s minimum bid price requirement for the continued listing on the NASDAQ Capital Market. InMed received a letter from the exchange notifying it of the extended deadline, which will now be Sept. 16, 2024. According to…

Thursday Mar 21, 2024 - 9:18 am

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced its financial numbers and operational highlights for the fourth quarter and full year ended Dec. 31, 2023. According to the report, key achievements during the period included enrolling the first patients for a pivotal trial studying AIMIGo(TM) System for synthesizing a 12-lead ECG as well…

Wednesday Mar 20, 2024 - 12:30 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Stockholders Vote to Approve Proposed MeridianBet Group Acquisition

Golden Matrix (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, is moving forward on the acquisition of MeridianBet Group. According to the announcement, GMGI stockholders approved the terms of the merger, which included the issuance of shares of common stock. The transaction was initially announced in June 2023. The announcement reported that stockholders representing 32,406,412…

Wednesday Mar 20, 2024 - 9:45 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into definitive agreements. The agreements are for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) of the company and warrants to purchase up to 1,542,112 shares of common stock; the stocks and warrants are offered at…

Wednesday Mar 20, 2024 - 9:28 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split of the company’s Class A common stock. The move was approved by the company’s board of directors during a special stockholder meeting. According to the announcement, the reverse split will become effective at 11:59 p.m. ET on March 26, 2024. Following that, the company’s Class…

Tuesday Mar 19, 2024 - 12:00 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 1,542,112 shares of common stock at a combined offering price of $4.215…

Tuesday Mar 19, 2024 - 11:31 am

InvestorNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in ‘First in Human’ Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, was featured in a recent episode of First in Human, a biotech-focused podcast featuring interviews with industry leaders and investors to learn about their journeys to in-human clinical trials. Hosted by Vial EVP Rich McCormick, the podcast is available for on-demand listening on First in Human by Vial. Rob Etherington, president, director and CEO of Clene joined…

Monday Mar 18, 2024 - 10:05 am

InvestorNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q4, FY 2023 Earnings Call

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, plans to release its financial results for the fourth quarter and fiscal year 2023 for the period ended Dec. 31, 2023 before market open on March 28, 2024. In addition, the company has scheduled a conference call that same day to discuss the…

Friday Mar 15, 2024 - 10:34 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced the publication of peer-reviewed research, titled “Protein Corona Composition of Gold Nanocrystals.” The publication appeared in the journal ACS Pharmacology & Translational Science and fully characterized the proteins from human…

Thursday Mar 14, 2024 - 12:47 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as…

Thursday Mar 14, 2024 - 12:00 pm

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has begun enrolling the first patients in its VALID-ECG pivotal study. According to the announcement, the first patients were enrolled at Atlanta Heart Specialists, a top cardiology physician practice in Atlanta, Georgia. HeartBeam anticipates the VALID-ECG study will form the basis of its planned FDA 510(k) submission.…

Thursday Mar 14, 2024 - 11:38 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Appoints Key Sales Personnel to Leadership

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced key personnel additions to support its commercial EV van and truck program. According to the announcement, the company has appointed Tyler Jordan as senior director of commercial sales, Matt Nevious as director of commercial sales and strategic accounts, and Jacob Frenning as director of commercial sales Mid-Atlantic. The new hires were a result…

Thursday Mar 14, 2024 - 10:19 am

InvestorNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Further Amendments to Iska Iska Payment Schedule

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, has amended the payment schedule for its Iska Iska silver-tin polymetallic project. The amendment was made by mutual agreement with Empresa Minera Villegas S.R.L., title holder of the project, which is located in the Potosi Department in southern Bolivia. This is the second time in the past month that Eloro…

Thursday Mar 14, 2024 - 9:33 am

InvestorNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Executives to Participate in 36th Annual Roth Conference

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced that CEO Dr. Alan Baratz and CFO John Markovich will present at the 36th Annual Roth Conference. The three-day event is scheduled for March 17–19, 2024, in Dana Point, California. According to the announcement, Dr. Baratz will also participate in…

Wednesday Mar 13, 2024 - 2:09 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Update on US Government Ruling for Class 1 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update on the U.S. Customs and Border Protection (“CBP”) application for Class 1 EV cargo vans. According to the announcement, the CBP, on March 5, 2024, informed Rapid Response Defense Systems (“RRDS”) counsel that a final determination on the ruling request needs to be issued by the U.S. General Services Administration (“GSA”).…

Wednesday Mar 13, 2024 - 11:54 am

InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Shares Vision, Innovations in ASD Treatments in Updated Company Presentation

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the release of its latest company presentation. The comprehensive overview showcases PaxMedica’s strategic direction, recent advancements in autism spectrum disorder (“ASD”) therapeutics, and its commitment to addressing unmet needs within the ASD community. “PaxMedica is pleased to share our vision and progress with the wider community,” said Howard Weisman, chairman…

Wednesday Mar 13, 2024 - 11:37 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces FY 2023 Results, Recent Operating Highlights

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced its full year 2023 financial results. In addition, the company provided recent operating highlights for the clinical programs in amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “In 2024 we…

Tuesday Mar 12, 2024 - 1:09 pm

InvestorNewsBreaks — Zoned Properties Inc. (ZDPY) Chooses IBN as Corporate Communications Partner

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry, is partnering with IBN, a multifaceted financial news and publishing company for private and public entities. According to the announcement, IBN will assist Zoned Properties with its corporate communications initiatives and help strengthen awareness of the company. Zoned Properties is focused on innovating in the…

Tuesday Mar 12, 2024 - 12:52 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Q4 and FY 2023 Earnings Release, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, today announced that it will provide a business update and release its financial results for the fourth quarter and full year 2023 following the close of the market on Thursday, March 28, 2024. On that same day at 2:30 p.m. PT (5:30 p.m. ET), Cepton will hold a conference call and…

Tuesday Mar 12, 2024 - 12:47 pm

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Showcasing Services, Meeting with Investors at Upcoming BIO-Europe Spring 2024

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing CDMO services through its Scinai Bioservices business unit, will be participating at this month’s BIO-Europe Spring 2024 conference. The conference is scheduled for March 18–20, 2024, in Barcelona. According to the announcement, Scinai management will be attending the event and will be available for discussions with…

Tuesday Mar 12, 2024 - 11:07 am

InvestorNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Announces Webinar Series Focused on Behavioral Health, First Segment Scheduled for March 27

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has unveiled a new behavioral-health webinar series. The slate of webinars will include industry leaders and focus on cutting-edge best practices. The first segment in the series is titled “The Future of Alcohol Monitoring Is Here: Discover Touch-Based Detection with SOBRsafe.” Hosted by Jason Wahler, a recovery advocate and TV personality, the webinar will include…

Tuesday Mar 12, 2024 - 9:44 am

InvestorNewsBreaks – ChatGPT Lists D-Wave Quantum Inc. (NYSE: QBTS) as One of Three Quantum Computing Stocks with 10x Potential

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, was one of three companies listed in a recent InvestorPlace article titled “ChatGPT Stock Predictions: 3 Quantum Computing Companies the AI Bot Thinks Have 10X Potential.” International Business Machines (NYSE: IBM) and Nvidia (NASDAQ: NVDA) were the other two companies mentioned. The article noted that the field of quantum computing may…

Monday Mar 11, 2024 - 10:25 am

InvestorNewsBreaks — Diamond Lake Minerals Inc. (DLMI) CEO, Advisory Board Member Spotlighted in Recent Proactive Broadcast

Diamond Lake Minerals (OTC: DLMI), a multistrategy operating company offering traditional investors an entry point to the future of digital securities, was featured in a recent Proactive release. A tech-enabled platform, Proactive works to empower companies globally with a comprehensive investor engagement solution across their business lifecycle. During the interview, which was held on International Women’s Day, Diamond Lake Minerals CEO Brian J. Esposito and…

Friday Mar 08, 2024 - 12:10 pm

InvestorNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Spotlighted in Weekly ‘New to the Street’ Segment

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, is featured in a recent “New to the Street” broadcast, slated to air on the Fox Business Network on March 11, 2024, at 10:30 p.m. PT. The episode features five corporate interviews, including the “Sekur Privacy & Sekur Security – Weekly Hack” segment with Sekur Private Data CEO Alain…

Thursday Mar 07, 2024 - 12:23 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO for Second DehydraTECH-Powered GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to perform the company’s second DehydraTECH-powered glucagon-like peptide 1 (“GLP-1”) human pilot study #2. According to the announcement, the study will be a randomized, crossover, placebo-controlled investigation that will compare three formulations, each at a 7 mg semaglutide dose: a positive control Rybelsus(R)…

InvestorNewsBreaks

NewsBreak Category: MissionIR

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions